(Q48616480)

13 February 2018

title

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. (English)

1 reference

13 February 2018

8

Ritsuko Komaki

1 reference

13 February 2018

Yun Oh

1

1 reference

13 February 2018

Sarah Taylor

2

1 reference

13 February 2018

Benjamin Nebiyou Bekele

3

1 reference

13 February 2018

J Matthew Debnam

4

1 reference

13 February 2018

Pamela K Allen

5

1 reference

13 February 2018

Dima Suki

6

1 reference

13 February 2018

Raymond Sawaya

7

1 reference

13 February 2018

David J Stewart

9

1 reference

13 February 2018

Daniel D Karp

10

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 July 2009

1 reference

13 February 2018

published in

Cancer

1 reference

13 February 2018

volume

115

1 reference

13 February 2018

issue

13

1 reference

13 February 2018

page(s)

2930-2938

1 reference

13 February 2018

State of the art in therapy for non-small cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

The volume of brain metastases may be of prognostic significance in patients with non-small-cell lung cancer classified as RTOG-RPA classes 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

Interstitial fluid pressure in intracranial tumours in patients and in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

Brain tumor volume measurement: comparison of manual and semiautomated methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

Tongue carcinoma: tumor volume measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Prognostic features of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Intracranial pressure monitoring after elective intracranial surgery. A retrospective study of 514 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Craniotomy for supratentorial brain tumors: risk factors for brain swelling after opening the dura mater

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Whole-brain radiotherapy in the management of brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Gamma knife surgery for brain metastases from lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Stereotactic radiotherapy for patients who initially presented with brain metastases from non-small cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Stereotactic radiosurgery for brain oligometastases: good for some, better for all?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Long-term survivors after gamma knife radiosurgery for brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Radiosurgery in metastatic brain cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Angiographic power 3-dimensional quantitative analysis in gynecologic solid tumors: feasibility and reproducibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.24333

1 reference

7 January 2021

Is there a favorable subset of patients with prostate cancer who develop oligometastases?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

The oligometastatic state in breast cancer: hypothesis or reality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Renal metastases from carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24333

7 January 2021

Identifiers

DOI

10.1002/CNCR.24333

1 reference

13 February 2018

1 reference

13 February 2018